StockData
Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc. (LUCD) stock

LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3034% above fair value
$0.40−0.05 (-11.42%)

Close on Nov 16, 2026Market cap $80.85MP/E –Yield –

Lucid Diagnostics cash

Cash and short-term investments held at the end of each period.

Lucid Diagnostics's cash was $33.40M at Jun 30, 2026. For fiscal 2025 it was $34.71M, up 55.2% from the year before. The highest annual figure on record is $53.66M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$34.71M+55.2%
FY2024Dec 31, 2024$22.36M+18.3%
FY2023Dec 31, 2023$18.90M-15.9%
FY2022Dec 31, 2022$22.47M-58.1%
FY2021Dec 31, 2021$53.66M+48238.7%
FY2020Dec 31, 2020$111.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$33.40M+7.3%
Q1 FY2026Mar 31, 2026$27.88M+10.5%
Q4 FY2025Dec 31, 2025$34.71M+55.2%
Q3 FY2025Sep 30, 2025$47.33M+226.7%
Q2 FY2025Jun 30, 2025$31.12M+24.9%
Q1 FY2025Mar 31, 2025$25.24M+1.9%
Q4 FY2024Dec 31, 2024$22.36M+18.3%
Q3 FY2024Sep 30, 2024$14.49M-39.8%
Q2 FY2024Jun 30, 2024$24.92M-23.5%
Q1 FY2024Mar 31, 2024$24.77M-37.3%
Q4 FY2023Dec 31, 2023$18.90M-15.9%
Q3 FY2023Sep 30, 2023$24.05M-10.7%
Q2 FY2023Jun 30, 2023$32.57M-0.3%
Q1 FY2023Mar 31, 2023$39.52M-17.5%
Q4 FY2022Dec 31, 2022$22.47M-58.1%
Q3 FY2022Sep 30, 2022$26.93M+126137.3%
Q2 FY2022Jun 30, 2022$32.68M+29340.5%
Q1 FY2022Mar 31, 2022$47.92M–
Q4 FY2021Dec 31, 2021$53.66M–
Q3 FY2021Sep 30, 2021$21.34K–
Q4 FY2020Dec 31, 2020$111.00K–

More Lucid Diagnostics figures

See a number that looks wrong?